Searched for
GRAM NEGATIVE PATHOGENS
Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...- Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
- Wockhardt gets CDSCO nod for Zaynich antibioticWockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...
- Wockhardt shares jump over 4%, extend two-day rally following FDA nod for ZaynichWockhardt Ltd shares jumped over 4% to ₹1,533, extending a two-day rally after surging nearly 20% on Tuesday. The rise follows the US FDA’s...
- USFDA accepts Wockhardt’s NDA for breakthrough antibiotic ZaynichThis is the first time ever that an NDA from a new chemical entity (NCE) from an Indian pharma company has been filed and accepted by the U...
- Wockhardt shares zoom 20% after USFDA’s historic approval for antibiotic drug ZaynichThe US FDA has accepted Wockhardt’s New Drug Application for Zaynich, its first-in-class antibiotic. This marks the first-ever acceptance o...
- Superbugs on the rise: One lakh lab samples show routine antibiotics no longer effective in IndiaIndia's common infections are becoming untreatable as widely used antibiotics lose efficacy, according to a new ICMR report. Bacteria causi...
- Wockhardt exits US generics biz to focus on drug discoveryWockhardt is set to exit its loss-making US generics business to prioritize innovation, focusing on new antibiotic drug discovery and its b...
- Wockhardt shares rise 10% after Zaynich aids successful liver transplant trialWockhardt's shares surged 8.6% after its antibiotic Zaynich successfully treated a US cancer patient, enabling a liver transplant and chemo...
- How an 80-year-old antibiotic can become a wonder drug to defeat world's most dangerous infectionsResearchers are studying streptothricin, an old antibiotic, for its potential to fight drug-resistant superbugs. The antibiotic, now named ...
- Wockhardt aims to launch antibiotic with USD 25 bn mkt potential by early FY26With strong financial backing and successful research, Wockhardt is poised for the launch of Zaynich, an antibiotic targeting high resistan...
- Researchers develop new class of antibiotics to fight drug-resistant bacteriaResearchers have developed a promising class of antibiotics targeting Carbapenem-resistant Acinetobacter baumannii (CRAB), a bacterium resi...
- This drug can fight more than 300 drug-resistant bacteriaA team of researchers have developed a novel drug molecule that can help ward off more than 300 drug-resistant bacteria.
- IIT Roorkee researchers find antibiotic against multi-drug resistant bacteriaIn a new study published in the journal, ‘Journal of Antimicrobial Chemotherapy’, IIT Roorkee researchers screened a library of 11,000 comp...
- Wockhardt gets QIDP status for new antibiotic product from FDAQIDP status is granted to drugs identified by Centre for Disease Control, US, that act against pathogens which have a high degree of unmet ...
- Silver can make antibiotics more effectiveSilver added to antibiotics could make them 10 to 1,000 times more effective and enable them to fight drug-resistant infections
- Superbug: British researchers challenge India's standThe researchers have challenged the stand of Indian health authorities who have been maintaining that drug-resistant pathogens such as the ...
Load More
